Please ensure Javascript is enabled for purposes of website accessibility
Eric Volkman

Eric Volkman


Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.

Recent articles

Gloved hand filling a syringe from a vial

Johnson & Johnson Coronavirus Vaccine Wins FDA Authorization

The big pharmaceutical company's jab has some important advantages.

Hand holding a marijuana cigarette

Cronos Group Slides on Q4 Results

The company's mixed quarter saw it trounce revenue estimates, but fall short of profitability forecasts.

A researcher studying a sample in a petri dish

Why AnaptysBio Was a Stock Market Star on Friday

There was some encouraging news from across the Atlantic.

Car nearing stop sign

Why Root Was a Flop on Friday

The company's Q4 performance fell short of expectations.

Hospital lobby

Why Select Medical Holdings Is Blasting 20% Higher Today

Critical care hospitalizations were up during the quarter, for obvious reasons.


Beyond Meat Signs Supply Deals With McDonald's and Yum! Brands, Releases Q4 Results

It was a good news, bad news kind of day for the alt-protein purveyor.

Plane taking off at dusk

Southwest Airlines Adds 2 New Strategic Routes

Travelers will soon be able to hop on the company's planes and fly to Montana or the Florida panhandle.

Apple iPhone 12 Pro and Pro Max

Apple Expanding Its Presence in Target Stores

The "enhanced Apple shopping experience" will start to be introduced in the next few days.

Dividends take a holiday

Why Airbnb Is a Hot Stock After-Hours Today

The company posts a massive revenue beat for its Q4, although its net loss was deeper than anticipated.

Green traffic light in the shape of a marijuana leaf

Why Green Thumb Industries Rose on Thursday Before Tanking by 5%

Jolts of optimism from two analysts can't overcome a downbeat day for the market.

Gloved hand holding a beaker full of money

Why Pandion Therapeutics Stock Blasted Sky-High on Thursday

You'd vault into the air too if a big-name pharmaceutical paid a high premium for your stock.

A woman looking at a set of indexes and graphs

Robinhood Fires Back at Berkshire Hathaway's Charlie Munger Over Criticism

The trading platform operator essentially accuses the Berkshire Hathaway vice chairman of being out of touch and elitist.

Stethoscope atop 100 dollar bills and pennies

Moderna's Market Value Set to Rise by at Least 75%, Says Noted Analyst

Oppenheimer's Hartaj Singh believes the stock's market capitalization is headed to at least $100 billion.

Marijuana bud on fire

Innovative Industrial Properties Misses on Q4 Results

The stock is being punished for not hitting analyst revenue and earnings estimates.


Costco Lifting Minimum Wage to $16 Per Hour, $1 Over Amazon, Walmart, and Target

It's also $1 higher than President Joe Biden's proposed hike.


Why Halozyme Therapeutics Is Trading 14% Higher Today

Investors liked what they saw in the company's fourth-quarter earnings release.

Stethoscope atop 100 dollar bills and pennies

Why Co-Diagnostics Stock Is Shooting Higher Today

Its technology underpins a coronavirus test that's about to get much wider distribution.

Marijuana flower being trimmed

Canopy Growth Is Poised to Fall by 35%, Says Analyst

The company isn't the best play on eventual U.S. decriminalization/legalization, according to a Jefferies prognosticator.


Report: AT&T Close to Selling Stake in DIRECTV, TV Now, and U-Verse Business Business

The deal could be worth around $15 billion.

A medical professional using a microscope

Co-Diagnostics Names New CFO and CSO

With the latter appointment, the company's founder moves into a more advisory role.